DiaCarta Revenue and Competitors
Estimated Revenue & Valuation
- DiaCarta's estimated annual revenue is currently $4.4M per year.
- DiaCarta received $45.0M in venture funding in February 2018.
- DiaCarta's estimated revenue per employee is $77,500
- DiaCarta's total funding is $53M.
Employee Data
- DiaCarta has 57 Employees.
- DiaCarta grew their employee count by -8% last year.
DiaCarta's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | Principal Financial Officer | Reveal Email/Phone |
3 | VP, Clinical Affairs | Reveal Email/Phone |
4 | Director, Manufacture | Reveal Email/Phone |
5 | R&D Director | Reveal Email/Phone |
6 | Sr. Director, R&D | Reveal Email/Phone |
7 | Scientist III/Technical Support Manager | Reveal Email/Phone |
8 | Manager Digital Marketing and Marketing Communication | Reveal Email/Phone |
9 | Office Manager | Reveal Email/Phone |
10 | Scientist / Asset Manager | Reveal Email/Phone |
DiaCarta Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is DiaCarta?
DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. To learn more, visit http://www.diacarta.com.
keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
$53M
Total Funding
57
Number of Employees
$4.4M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
DiaCarta News
Amgen; Bluebird Bio; Celgene Corporation; Cellectis; DiaCarta; Fate Therapeutics; Gilead Sciences; Juno Therapeutics; Kite Pharma; Merck; Novartis; Pfizer...
PLEASANTON, Calif. , April 7, 2022 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel...
AZ: DiaCarta is a molecular diagnostics company borne out of decades of research in next-generation sequencing (NGS), circulating cell-free DNA...
RICHMOND, Calif.--(BUSINESS WIRE)--DiaCarta today announced that CIO Bulletin has named it among the 30 Fastest Growing Companies ...
BUSINESS WIRE)--DIACARTA, Inc., a precision diagnostic company and leading developer of products for nucleic acid-based detection ...
Other Companies in Richmond
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 57 | 19% | N/A |
#2 | $7.2M | 57 | 0% | N/A |
#3 | $5.1M | 57 | 19% | N/A |
#4 | $13.9M | 57 | 8% | N/A |
#5 | $9.2M | 57 | -11% | N/A |
DiaCarta Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2015-01-12 | $8.0M | A | BVCF | Article |
| 2018-02-13 | $45.0M | B | Fortune Fountain Capital | Article |